NASDAQ:CDMOP

Avid Bioservices Stock Forecast, Price & News

$25.06
0.00 (0.00 %)
(As of 04/13/2021 12:00 AM ET)
Add
Compare
Today's Range
$25.06
Now: $25.06
$25.06
50-Day Range
$25.03
MA: $26.66
$31.36
52-Week Range
$21.00
Now: $25.06
$31.95
Volume400 shs
Average Volume11,022 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend Yield9.49%
BetaN/A
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. It produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, purification, bulk packaging, release and stability testing, and regulatory submission and support. The company also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. It serves biotechnology and pharmaceutical companies. Avid Bioservices, Inc. has a process development and manufacturing agreement with Oragenics, Inc. to develop coronavirus vaccine. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was founded in 1981 and is headquartered in Tustin, California.
Avid Bioservices logo

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:CDMOP
CUSIPN/A
CIKN/A
Phone714 508 6100
Employees222
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

MarketRank

Overall MarketRank

0.33 out of 5 stars

Medical Sector

1784th out of 2,019 stocks

Biotechnology Industry

114th out of 145 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$25.06
0.00 (0.00 %)
(As of 04/13/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CDMOP News and Ratings via Email

Sign-up to receive the latest news and ratings for CDMOP and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Avid Bioservices (NASDAQ:CDMOP) Frequently Asked Questions

What stocks does MarketBeat like better than Avid Bioservices?

Wall Street analysts have given Avid Bioservices a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Avid Bioservices wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Avid Bioservices?

Avid Bioservices saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 5,800 shares, an increase of 728.6% from the March 15th total of 700 shares. Based on an average trading volume of 11,300 shares, the days-to-cover ratio is presently 0.5 days.
View Avid Bioservices' Short Interest
.

How often does Avid Bioservices pay dividends? What is the dividend yield for Avid Bioservices?

Avid Bioservices announced a quarterly dividend on Friday, March 5th. Stockholders of record on Monday, March 15th will be given a dividend of $0.6563 per share on Thursday, April 1st. This represents a $2.63 dividend on an annualized basis and a yield of 10.47%. The ex-dividend date of this dividend is Friday, March 12th.
View Avid Bioservices' dividend history
.

Is Avid Bioservices a good dividend stock?

Avid Bioservices pays an annual dividend of $2.63 per share and currently has a dividend yield of 9.49%. CDMOP has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
View Avid Bioservices' dividend history.

Who are Avid Bioservices' key executives?

Avid Bioservices' management team includes the following people:
  • Mr. Daniel R. Hart, Chief Financial Officer (Age 48, Pay $488.87k)
  • Mr. Mark R. Ziebell, VP, Gen. Counsel & Corp. Sec. (Age 57, Pay $662.28k)
  • Mr. Nicholas Stewart Green, Pres, CEO & Director (Age 56)
  • Mr. Richard Richieri, Chief Operations Officer (Age 56)
  • Ms. Lorna Larson, Sr. Director of HR
  • Mr. Timothy Compton, Chief Commercial Officer
  • Dr. Shelley P. M. Fussey, VP of Intellectual Property (Age 55)
  • Ms. Tracy L. Kinjerski, VP of Bus. Operations
  • Mr. Harold F. Dvorak, Medical & Scientific Advisor
  • Prof. Alan J. Schroit, Medical & Scientific Advisor

Who are some of Avid Bioservices' key competitors?

What is Avid Bioservices' stock symbol?

Avid Bioservices trades on the NASDAQ under the ticker symbol "CDMOP."

How do I buy shares of Avid Bioservices?

Shares of CDMOP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Avid Bioservices' stock price today?

One share of CDMOP stock can currently be purchased for approximately $25.06.

How many employees does Avid Bioservices have?

Avid Bioservices employs 222 workers across the globe.

What is Avid Bioservices' official website?

The official website for Avid Bioservices is www.avidbio.com.

How can I contact Avid Bioservices?

The company can be reached via phone at 714 508 6100.


This page was last updated on 4/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.